Moffitt logo

COVID-19 UPDATE: Moffitt is offering third doses and vaccine booster shotsLearn More

Clinical Trials Search

Clinical Trial 20915

Cancer Type: Breast
Study Type: Treatment
NCT#:

Phase: Phase II
Prinicipal Investigator: Han, Heather

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

A Phase II Study of HER2 directed Dendritic Cell (DC1) vaccine Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients with HER-2 Positive Breast Cancer

Summary

Objective

Treatments

Therapies

Chemotherapy (NOS); Immunotherapy; Surgery; Vaccine

Medications

DC1 Vaccine (); Herceptin (Trastuzumab); Pertuzumab (); Taxol (paclitaxel); Trastuzumab (); paclitaxel (); rhuMAb HER2 (Trastuzumab)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.